Recent presentations of UROBEST in international meetings
Press release March 8th, 2017 RECENT PRESENTATIONS OF UROBEST IN INTERNATIONAL MEETINGS UROBEST has been presented in both the 23rd Meeting of the EAU Section of Urological Research (ESUR) held [...]
Biofina Diagnostics S.L. attends BIOSPAIN 2016
Biofina Diagnostics S.L. has recently attended BIOSPAIN2016, the 8th edition of the International Meeting on Biotechnology which took place in Bilbao (Spain) from the 28th to 30th of September. BIOSPAIN [...]
Biofina Diagnostics S.L has recently attended the 111th American Urological Association’s Annual Meeting (AUA2016) held in San Diego, California, from the 6th until the 10th of May.
Press release May 18th, 2016 Biofina Diagnostics S.L has recently attended the 111th American Urological Association's Annual Meeting (AUA2016) held in San Diego, California, from the 6th until the 10th of [...]
Dr. Maria J. Ribal participates in the AUA 2016
Dr. Maria J. Ribal has participated in a Plenary session titled “Complex cases in Bladder Cancer: High Grade Superficial TCAA When There Is No BCG o BCG Fails” during the [...]
-
http://finabiotech.es/wp-content/uploads/2016/04/2016-03-30_BIOFINA-WEB_Press-release-Poster-AUA-San-Diego.pdf GalleryPress release – Biofina Diagnostics S.L will be attending the 111th American Urological Association’s Annual Meeting to be held in San Diego, California, from the 6th until the 10th of May.
Press release – Biofina Diagnostics S.L will be attending the 111th American Urological Association’s Annual Meeting to be held in San Diego, California, from the 6th until the 10th of May.
Biofina Diagnostics S.L will be attending the 111th American Urological Association's Annual Meeting to be held in San Diego, California, from the 6th until the 10th of May. Dr. Mengual [...]
Press release – Biofina Diagnostics announces two patents were granted in the U.S. and in Canada, from family “BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS METHOD”.
Biofina Diagnostics announces that two new patents have been granted in 2015 in the United States and in Canada, both belonging to the patent family “BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS [...]
